AORT SEC Filing News — Artivion, Inc.

Latest SEC filings for Artivion, Inc. (AORT) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-11.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic…
Sector: Healthcare Industry: Medical Devices Market Cap: $1.1B CIK: 784199
20
Total Filings
0
Bullish Classifications
7
Bearish Classifications
10
Insider Transactions
1
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for AORT currently lean bearish. Of the 20 filing records displayed, 7 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
AORT Filing Activity Snapshot 2026-05-20 — 2026-09-11
Insider Transactions (Form 4)
0 buys vs 7 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$2.05M
Mackin James P · 2026-08-19
70,000 shares · Form 144
Form 144 Notices
8
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 10 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 10 filings in this group are Form 4s for Artivion, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 10 insider filings shown, the breakdown is 7 open-market sale, 2 compensation award and 1 other reported transaction. 7 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×7
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Compensation award ×2
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Other reported transaction ×1
The filing reports a transaction type that does not map to a routine purchase, sale, award or withholding.
Form 4 Open-market sale Insider Selling 2026-09-11

AORT insider GREEN ANDREW M (SVP, Regulatory and Quality) sold 11,480 shares (~$286.7K)

GREEN ANDREW M, listed as SVP, Regulatory and Quality at ARTIVION, INC., reported an open-market sale of 11,480 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 11,480 $24.97 $286.7K
Filing: Form 4 (Insider Transaction) Insider: GREEN ANDREW M (SVP, Regulatory and Quality) Shares: 11,480 Est. Value: $286.7K
Form 4 Open-market sale Insider Selling 2026-09-04

AORT insider GREEN ANDREW M (SVP, Regulatory and Quality) sold 8,003 shares (~$216.3K)

GREEN ANDREW M, listed as SVP, Regulatory and Quality at ARTIVION, INC., reported an open-market sale of 8,003 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 6,510 $27.27 $177.5K
S Open-market sale 1,493 $26.02 $38.8K
Filing: Form 4 (Insider Transaction) Insider: GREEN ANDREW M (SVP, Regulatory and Quality) Shares: 8,003 Est. Value: $216.3K
Form 4 Open-market sale Insider Selling 2026-08-20

AORT insider Mackin James P (President & CEO) sold 70,000 shares (~$2.03M)

Mackin James P, listed as President & CEO at ARTIVION, INC., reported an open-market sale of 70,000 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 70,000 $28.95 $2.03M
Filing: Form 4 (Insider Transaction) Insider: Mackin James P (President & CEO) Shares: 70,000 Est. Value: $2.03M
Form 4 Open-market sale Insider Selling 2026-08-17

AORT insider GREEN ANDREW M (SVP, Regulatory and Quality) sold 616 shares (~$17.6K)

GREEN ANDREW M, listed as SVP, Regulatory and Quality at ARTIVION, INC., reported an open-market sale of 616 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 616 $28.55 $17.6K
Filing: Form 4 (Insider Transaction) Insider: GREEN ANDREW M (SVP, Regulatory and Quality) Shares: 616 Est. Value: $17.6K
Form 4 Open-market sale Insider Selling 2026-08-17

AORT insider Berry Lance A (EVP, COO, CFO & Treasurer) sold 715 shares (~$20.4K)

Berry Lance A, listed as EVP, COO, CFO & Treasurer at ARTIVION, INC., reported an open-market sale of 715 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 715 $28.55 $20.4K
Filing: Form 4 (Insider Transaction) Insider: Berry Lance A (EVP, COO, CFO & Treasurer) Shares: 715 Est. Value: $20.4K
Form 4 Open-market sale Insider Selling 2026-08-12

AORT insider Holloway Jean F (SVP, General Counsel) sold 977 shares (~$27.8K)

Holloway Jean F, listed as SVP, General Counsel at ARTIVION, INC., reported an open-market sale of 977 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 977 $28.49 $27.8K
Filing: Form 4 (Insider Transaction) Insider: Holloway Jean F (SVP, General Counsel) Shares: 977 Est. Value: $27.8K
Form 4 Open-market sale Insider Selling 2026-06-15

AORT insider GREEN ANDREW M (SVP, Regulatory and Quality) sold 44,001 shares (~$910.7K)

GREEN ANDREW M, listed as SVP, Regulatory and Quality at ARTIVION, INC., reported an open-market sale of 44,001 AORT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 14,001 $18.44 $258.2K
S Open-market sale 14,001 $20.71 $289.9K
M Option exercise 30,000 $11.03 $330.9K
S Open-market sale 30,000 $20.69 $620.8K
M Option exercise derivative · Stock Options (Right to buy) 14,001 — —
M Option exercise derivative · Stock Options (Right to buy) 30,000 — —
Filing: Form 4 (Insider Transaction) Insider: GREEN ANDREW M (SVP, Regulatory and Quality) Shares: 44,001 Est. Value: $910.7K
Form 4 Other reported transaction Tax / Compensation Filing 2026-06-04

AORT insider Form 4 filed for equity award, exercise, or tax withholding

SEMEDO ANTHONY B. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The filing reports a transaction type that does not map to a routine purchase, sale, award or withholding.

Transactions reported on this filing
Code Nature Shares Price Value
J Other transaction 6,325 — —
J Other transaction 6,325 — —
Filing: Form 4 (Insider Transaction) Insider: SEMEDO ANTHONY B. (Director) Shares: 12,650
Form 4 Compensation award Tax / Compensation Filing 2026-05-20

AORT insider Form 4 filed for equity award, exercise, or tax withholding

SEMEDO ANTHONY B. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 7,576 — —
Filing: Form 4 (Insider Transaction) Insider: SEMEDO ANTHONY B. (Director) Shares: 7,576
Form 4 Compensation award Tax / Compensation Filing 2026-05-20

AORT insider Form 4 filed for equity award, exercise, or tax withholding

Salveson Jon W (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 7,576 — —
Filing: Form 4 (Insider Transaction) Insider: Salveson Jon W (Director) Shares: 7,576
Proposed Insider Sales 8 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Artivion, Inc. has 8 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-10

AORT Form 144 filed for proposed insider sale by GREEN ANDREW M (11,480 shares) ~$286.7K

GREEN ANDREW M filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GREEN ANDREW M Shares: 11,480 Est. Value: $286.7K
Form 144 Proposed Insider Sale 2026-09-03

AORT Form 144 filed for proposed insider sale by GREEN ANDREW M (1,493 shares) ~$38.8K

GREEN ANDREW M filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GREEN ANDREW M Shares: 1,493 Est. Value: $38.8K
Form 144 Proposed Insider Sale 2026-09-02

AORT Form 144 filed for proposed insider sale by GREEN ANDREW M (6,510 shares) ~$177.5K

GREEN ANDREW M filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GREEN ANDREW M Shares: 6,510 Est. Value: $177.5K
Form 144 Proposed Insider Sale 2026-08-27

AORT Form 144 filed for proposed insider sale by Stanton Marshall S. (7,400 shares) ~$198.7K

Stanton Marshall S. filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Stanton Marshall S. Shares: 7,400 Est. Value: $198.7K
Form 144 Proposed Insider Sale 2026-08-19

AORT Form 144 filed for proposed insider sale by Mackin James P (70,000 shares) ~$2.05M

Mackin James P filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Mackin James P Shares: 70,000 Est. Value: $2.05M
Form 144 Proposed Insider Sale 2026-08-14

AORT Form 144 filed for proposed insider sale by Berry Lance A (715 shares) ~$20.4K

Berry Lance A filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Berry Lance A Shares: 715 Est. Value: $20.4K
Form 144 Proposed Insider Sale 2026-08-14

AORT Form 144 filed for proposed insider sale by GREEN ANDREW M (616 shares) ~$17.6K

GREEN ANDREW M filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GREEN ANDREW M Shares: 616 Est. Value: $17.6K
Form 144 Proposed Insider Sale 2026-06-11

AORT Form 144 filed for proposed insider sale by GREEN ANDREW M (44,001 shares) ~$910.8K

GREEN ANDREW M filed a Form 144 with the SEC indicating intent to sell AORT (ARTIVION, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GREEN ANDREW M Shares: 44,001 Est. Value: $910.8K
Material Events 1 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There is 1 in this period for Artivion, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-08-06

AORT filed 8-K — material company event

ARTIVION, INC. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Artivion, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-07

AORT filed Quarterly Report (10-Q)

ARTIVION, INC. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify Artivion, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on AORT. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — AORT SEC Filings

More Tools for AORT

Want deeper AORT analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the AORT stock analysis page.

AORT Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer